论文部分内容阅读
目的:研究醒脑静注射液在重度脑外伤中的应用价值。方法:选取在2011年9月-2013年9月期间常德市第一人民医院收治的重度脑外伤患者58例,采用单双号法将患者分为两组,每组各29例。其中对照组行常规治疗,观察组在对照组的基础上取醒脑静注射液,分析两组患者的临床疗效以及并发症发生率。结果:观察组患者的良好率、重残、死亡率分别为51.72%、13.79%、3.45%,对照组患者的良好率、重残、死亡率分别为13.79%、31.03%、20.69%,差异具有统计学意义(P<0.05);观察组并发症发生率较对照组高,但两组比较,差异无统计学意义(P>0.05)。结论:重度脑外伤患者入院后,在常规治疗的基础上采取醒脑静注射液治疗,不仅能够有效控制疾病的发展,更有利于提高其预后生活质量。
Objective: To study the value of Xingnaojing injection in severe traumatic brain injury. Methods: Fifty-eight patients with severe traumatic brain injury admitted to the First People’s Hospital of Changde from September 2011 to September 2013 were enrolled. Patients were divided into two groups (n = 29) by single and double number method. The control group was treated routinely. The observation group took XNX injection on the basis of the control group, and the clinical efficacy and the complication rate of the two groups were analyzed. Results: The good rate, severe disability and death rate in the observation group were 51.72%, 13.79% and 3.45% respectively. The good rate, severe disability and mortality in the control group were 13.79%, 31.03% and 20.69%, respectively Statistical significance (P <0.05). The incidence of complications in the observation group was higher than that in the control group, but there was no significant difference between the two groups (P> 0.05). Conclusion: After severe traumatic brain injury patients admitted to hospital, taking Xingnaojing Injection on the basis of routine treatment can not only effectively control the development of the disease, but also help to improve their prognosis quality of life.